ArticleInternational journal of oncology2013

Potent activity of the Hsp90 inhibitor ganetespib in prostate cancer cells irrespective of androgen receptor status or variant receptor expression.

Suqin He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.